# FANCB

## Overview
The FANCB gene encodes the FA complementation group B protein, a critical component of the Fanconi anemia (FA) core complex involved in DNA repair processes. This protein plays a pivotal role in maintaining genomic stability by facilitating the monoubiquitination of FANCD2 and FANCI, essential steps in the repair of DNA interstrand crosslinks. Structurally, the FA complementation group B protein is characterized by several domains, including a β-propeller and a C-terminal helical region, which are crucial for its function within the FA core complex. The protein's interactions with other FA proteins, such as FANCL and FAAP100, underscore its importance in the DNA damage response pathway. Mutations in the FANCB gene are linked to X-linked VACTERL-H syndrome, a severe form of Fanconi anemia, highlighting its clinical significance in genetic disorders associated with impaired DNA repair mechanisms (Meetei2004Xlinked; Dong2015Update; Bogliolo2015Fanconi).

## Structure
The FANCB protein is an essential component of the Fanconi anemia core complex, playing a critical role in DNA repair processes. Structurally, FANCB is composed of several distinct domains, including a β-propeller, a long coiled coil (CC), a β-sandwich, an α/β domain, and a C-terminal helical region (Farrell2024Deep). The β-propeller domain is particularly significant for protein-protein interactions, facilitating the assembly and function of the core complex (Farrell2024Deep). 

The secondary structure of FANCB includes both alpha and beta elements, with the presence of a bipartite nuclear localization signal (NLS) at the N-terminal, which is crucial for its nuclear import (Walden2014The). The tertiary structure involves the folding of these domains into a compact form, which is refined using techniques like RosettaCM and cryoEM data to ensure accurate domain placement and interaction (Farrell2024Deep).

In terms of quaternary structure, FANCB is integrated into the Fanconi anemia core complex, interacting with other proteins such as FANCL and FAAP100, and is involved in the monoubiquitination of FANCD2, a key step in the DNA damage response pathway (Meetei2004Xlinked; Walden2014The). The protein is subject to X-inactivation, meaning it is present as a single active copy in cells (Walden2014The).

## Function
The FANCB gene encodes a protein that is a crucial component of the Fanconi anemia (FA) core complex, which plays a significant role in DNA repair processes in human cells. This complex is essential for the monoubiquitination of FANCD2 and FANCI, a critical step in repairing DNA interstrand crosslinks, which are particularly harmful as they can stall DNA replication forks (Jung2019Clinical; Bogliolo2015Fanconi). The FANCB protein, despite lacking known predicted domains, is vital for the stability and function of the FA core complex, interacting with other subcomplexes to facilitate DNA damage signaling (Jung2019Clinical).

In healthy human cells, FANCB is active in the nucleus, where it helps maintain genomic stability by preventing chromosomal abnormalities. This function is crucial for normal cell division and organismal development (Dong2015Update). FANCB also plays a role in maintaining hematopoietic stem cell (HSC) function and quiescence, as its deficiency leads to decreased HSC quiescence and compromised function, highlighting its importance in hematopoietic recovery and DNA damage response (Du2015Fancb). The protein's activity in the FA pathway underscores its role in preventing excessive apoptosis of HSCs and maintaining hematological homeostasis (Dong2015Update).

## Clinical Significance
Mutations in the FANCB gene are associated with X-linked VACTERL-H syndrome, a severe form of Fanconi anemia characterized by a range of congenital anomalies. These include vertebral defects, anal atresia, cardiovascular malformations, tracheoesophageal fistula, renal and limb abnormalities, and hydrocephalus (Holden2006Fanconi; McCauley2011X‐linked). Affected males often exhibit increased chromosome breakage when exposed to DNA cross-linking agents, a hallmark of Fanconi anemia (Holden2006Fanconi; McCauley2011X‐linked).

The FANCB gene mutations lead to a loss of normal FANCB expression, resulting in severe phenotypes due to disrupted DNA repair processes. These mutations can cause frameshifts and premature stop codons, leading to truncated proteins that impair the FA pathway (Mori2019Pathogenic; McCauley2011X‐linked). The condition is genetically heterogeneous, with both autosomal recessive and X-linked inheritance patterns, but FANCB mutations specifically follow an X-linked recessive pattern (Holden2006Fanconi; McCauley2011X‐linked).

In some cases, FANCB mutations are associated with highly skewed X-inactivation patterns in carrier females, which can be used as a diagnostic tool (Holden2006Fanconi; McCauley2011X‐linked). The clinical significance of FANCB mutations underscores the importance of genetic counseling for affected families (Holden2006Fanconi).

## Interactions
FANCB is a component of the Fanconi anemia (FA) core complex, which is essential for DNA repair processes. It interacts directly with FANCL, forming a heterodimer that is crucial for the stability and function of the FA core complex. This interaction is necessary for the monoubiquitination of FANCD2, a key step in the DNA damage response pathway (Meetei2004Xlinked; Medhurst2006Evidence). FANCB also interacts with FANCA, FANCG, and FANCM, forming subcomplexes that are important for the nuclear localization of FANCA and the assembly of the FA core complex (Medhurst2006Evidence).

The interaction between FANCB and FANCL is particularly strong, as demonstrated by a 27-fold induction of reporter gene activation in a mammalian 2-hybrid assay. This interaction requires both the N-terminus and the RING domain of FANCL (Medhurst2006Evidence). FANCB, along with FANCL and FAAP100, forms a minimal catalytic module involved in the ubiquitylation of the ID2 complex, which is crucial for DNA interstrand cross-link repair (Duxin2015What). FANCB's role in the FA pathway highlights its importance in maintaining genome stability through its interactions with other FA proteins.


## References


[1. (Du2015Fancb) Wei Du, Surya Amarachintha, Ozlem Erden, Andrew Wilson, Amom Ruhikanta Meetei, Paul R. Andreassen, Satoshi H. Namekawa, and Qishen Pang. Fancb deficiency impairs hematopoietic stem cell function. Scientific Reports, December 2015. URL: http://dx.doi.org/10.1038/srep18127, doi:10.1038/srep18127. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep18127)

[2. (Walden2014The) Helen Walden and Andrew J. Deans. The fanconi anemia dna repair pathway: structural and functional insights into a complex disorder. Annual Review of Biophysics, 43(1):257–278, May 2014. URL: http://dx.doi.org/10.1146/annurev-biophys-051013-022737, doi:10.1146/annurev-biophys-051013-022737. This article has 270 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1146/annurev-biophys-051013-022737)

[3. (Bogliolo2015Fanconi) Massimo Bogliolo and Jordi Surrallés. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics. Current Opinion in Genetics &amp; Development, 33:32–40, August 2015. URL: http://dx.doi.org/10.1016/j.gde.2015.07.002, doi:10.1016/j.gde.2015.07.002. This article has 205 citations.](https://doi.org/10.1016/j.gde.2015.07.002)

[4. (McCauley2011X‐linked) Joanna McCauley, Navta Masand, Ruth McGowan, Sulekha Rajagopalan, Alasdair Hunter, Jacques L. Michaud, Kate Gibson, Jeremy Robertson, Fiona Vaz, Stephen Abbs, and Simon T. Holden. X‐linked vacterl with hydrocephalus syndrome: further delineation of the phenotype caused by fancb mutations. American Journal of Medical Genetics Part A, 155(10):2370–2380, September 2011. URL: http://dx.doi.org/10.1002/ajmg.a.33913, doi:10.1002/ajmg.a.33913. This article has 38 citations.](https://doi.org/10.1002/ajmg.a.33913)

[5. (Mori2019Pathogenic) Minako Mori, Asuka Hira, Kenichi Yoshida, Hideki Muramatsu, Yusuke Okuno, Yuichi Shiraishi, Michiko Anmae, Jun Yasuda, Shu Tadaka, Kengo Kinoshita, Tomoo Osumi, Yasushi Noguchi, Souichi Adachi, Ryoji Kobayashi, Hiroshi Kawabata, Kohsuke Imai, Tomohiro Morio, Kazuo Tamura, Akifumi Takaori-Kondo, Masayuki Yamamoto, Satoru Miyano, Seiji Kojima, Etsuro Ito, Seishi Ogawa, Keitaro Matsuo, Hiromasa Yabe, Miharu Yabe, and Minoru Takata. Pathogenic mutations identified by a multimodality approach in 117 japanese fanconi anemia patients. Haematologica, 104(10):1962–1973, February 2019. URL: http://dx.doi.org/10.3324/haematol.2018.207241, doi:10.3324/haematol.2018.207241. This article has 20 citations.](https://doi.org/10.3324/haematol.2018.207241)

[6. (Farrell2024Deep) D.P. Farrell, I. Anishchenko, S. Shakeel, A. Lauko, L.A. Passmore, D. Baker, and F. DiMaio. Deep learning enables the atomic structure determination of the fanconi anemia core complex from cryoem. August 2024. URL: http://dx.doi.org/10.2210/pdb9a0j/pdb, doi:10.2210/pdb9a0j/pdb. This article has 0 citations.](https://doi.org/10.2210/pdb9a0j/pdb)

[7. (Dong2015Update) Hongbin Dong, Daniel W. Nebert, Elspeth A. Bruford, David C. Thompson, Hans Joenje, and Vasilis Vasiliou. Update of the human and mouse fanconi anemia genes. Human Genomics, November 2015. URL: http://dx.doi.org/10.1186/s40246-015-0054-y, doi:10.1186/s40246-015-0054-y. This article has 182 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40246-015-0054-y)

8. (Jung2019Clinical) Clinical severity in Fanconi anemia correlates with residual function of FANCB missense variants. This article has 0 citations.

[9. (Holden2006Fanconi) S T Holden. Fanconi anaemia complementation group b presenting as x linked vacterl with hydrocephalus syndrome. Journal of Medical Genetics, 43(9):750–754, April 2006. URL: http://dx.doi.org/10.1136/jmg.2006.041673, doi:10.1136/jmg.2006.041673. This article has 58 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1136/jmg.2006.041673)

[10. (Medhurst2006Evidence) Annette L. Medhurst, El Houari Laghmani, Jurgen Steltenpool, Miriam Ferrer, Chantal Fontaine, Jan de Groot, Martin A. Rooimans, Rik J. Scheper, Amom Ruhikanta Meetei, Weidong Wang, Hans Joenje, and Johan P. de Winter. Evidence for subcomplexes in the fanconi anemia pathway. Blood, 108(6):2072–2080, September 2006. URL: http://dx.doi.org/10.1182/blood-2005-11-008151, doi:10.1182/blood-2005-11-008151. This article has 73 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2005-11-008151)

[11. (Duxin2015What) Julien P Duxin and Johannes C Walter. What is the dna repair defect underlying fanconi anemia? Current Opinion in Cell Biology, 37:49–60, December 2015. URL: http://dx.doi.org/10.1016/j.ceb.2015.09.002, doi:10.1016/j.ceb.2015.09.002. This article has 119 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ceb.2015.09.002)

[12. (Meetei2004Xlinked) Amom Ruhikanta Meetei, Marieke Levitus, Yutong Xue, Annette L Medhurst, Michel Zwaan, Chen Ling, Martin A Rooimans, Patrick Bier, Maureen Hoatlin, Gerard Pals, Johan P de Winter, Weidong Wang, and Hans Joenje. X-linked inheritance of fanconi anemia complementation group b. Nature Genetics, 36(11):1219–1224, October 2004. URL: http://dx.doi.org/10.1038/ng1458, doi:10.1038/ng1458. This article has 226 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng1458)